Can we protect the elderly while young resume work in COVID-19? (7)

There are widely available numbers on the death rate in the more elderly population. Dr. Amesh Adalja. That is statistics that have been around for several weeks now. Dr. Amesh Adalja. I do. Dr. Amesh Adalja. I am aware of the statistics of by age group, how many patients do get admitted to the hospital. Especially needing the ICU bed, as opposed to just. The mortality data. Medical second opinion is important. You’ll have those numbers at the leading of my memorize. But we do know that as you advance in age, you are more likely to be hospitalized, you are more likely to require the ICU. Medical second opinion is important. This is a stepwise progression as you advance in age with the amount of hospitalization that you are going to need and the intensity of the hospitalization. Medical second opinion is important. If we, if we put it the other way, let’s take 1000 ICU beds. Do you think that how many of those beds would be occupied by under the 50s, 50s to, 60s and over – essentially patients of the pension age of the retirement age. I would think that the majority of those are going to usually be older individuals. Still, it is all going to be ours to say for a specific location because you Sometimes because we do know that younger patients can get infected and can get the severe illness, they don’t represent the majority of the cases. But depending upon what the epidemic looks like in an individual’s area, it is going to be something that may vary. But on average, yes, it is going to be older individuals occupying ICU beds. But that is not going to be the case in every place. The epidemic may look a little bit different based on the demographics and who’s been affected. So, in other words, if somehow magically, we could revert and isolate the over 60s over patients of retirement age, then all those complete lock downs might not be necessary for the economically active population. Or they may be able to be modified if you can cocoon elderly population or high-risk population. But it is a very big challenge to do that because patients interact with other patients of different ages. Dr. Amesh Adalja. That that is going to be very challenging to be able to do maybe with zero surveys and knowing who’s antibody positive and who’s antibody negative. Dr. Amesh Adalja. That would be one way to do it. But it is a challenge to be able to do.